tirzepatide egfr cut off A comparison of the effects of and dulaglutide on major kidney events in people with type 2 diabetes: pre-specified exploratory analyses of the SURPASS-CVOT trial Not all GLP-1 receptor agonists

Nassif ME, Windsor SL, Tang F, Khariton Y, Husain M, Inzucchi SE, McGuire DK, Pitt B, Scirica BM, Austin B, Drazner MH, Fong MW, Givertz MM, Gordon RA, Jermyn R, Katz SD, Lamba S, Lanfear DE, LaRue SJ, Lindenfeld J, Malone M, Margulies K, Mentz RJ, Mutharasan RK, Pursley M, Umpierrez G, Kosiborod M

January 13, 2025

If you are experiencing heavy periods whilst taking Ozempic, your healthcare team will need to determine whether the medication should be continued, adjusted, or temporarily stopped whilst investigations proceed

G., Samuelson, A

Some patients may transition to physician-supervised semaglutide after an individualized evaluation